ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $69,000 | -44.8% | 609 | -32.7% | 0.00% | -50.0% |
| Q4 2020 | $125,000 | -1.6% | 905 | -41.3% | 0.00% | -33.3% |
| Q3 2020 | $127,000 | -42.8% | 1,543 | -47.0% | 0.00% | -62.5% |
| Q3 2018 | $222,000 | +335.3% | 2,910 | +164.5% | 0.01% | +100.0% |
| Q4 2017 | $51,000 | -75.8% | 1,100 | -67.7% | 0.00% | -81.0% |
| Q2 2017 | $211,000 | +2.4% | 3,402 | +12.0% | 0.02% | -16.0% |
| Q1 2017 | $206,000 | +18.4% | 3,037 | +22.6% | 0.02% | 0.0% |
| Q4 2016 | $174,000 | +9.4% | 2,477 | +10.7% | 0.02% | +4.2% |
| Q3 2016 | $159,000 | +59.0% | 2,237 | +9.4% | 0.02% | +50.0% |
| Q2 2016 | $100,000 | – | 2,045 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |